3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT05039268 · COMPLETED

Trial details

NCT number: NCT05039268
Sponsor: Macquarie University, Australia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-11-25
Primary completion: 2022-09-12
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.